Solventum
Eagan, Minnesota, United States · Biotechnology, Health Care, Manufacturing
Solventum is a healthcare innovation company dedicated to enabling better, smarter, and safer care. Building on a long legacy of breakthrough solutions, we pioneer advancements at the intersection of health, materials, and data science—transforming patient outcomes and empowering healthcare professionals to perform at their best.
Key facts
- Headquarters
- Eagan, Minnesota, United States
- Employees
- 20,000
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Public (SOLV)
- Website
- www.solventum.com
- Company page
Recent activity at Solventum
- : Minnesota Wild Partners with Solventum to Promote Oral Health through Nordy’s Chipped Tooth Campaign
- : SEC 8-K (8.01): On August 5, 2026, Solventum Corporation announced its intention to separate its Health Information Systems business as part of a strategic portfolio optimization effort. This decision reflects the company's ongoing strategy to enhance focus and efficiency in its operations. The announcement is detailed in the attached press release, which outlines the strategic rationale behind the separation and its potential impact on the company. This event signifies a significant shift in the company's operational focus, aimed at maximizing shareholder value.
- : Solventum Appoints Neil Zieselman as Chief Accounting Officer
- : SEC 8-K (5.02):
- : SEC 8-K (8.01): On June 2, 2026, the Delaware Court entered an order approving a payment of $120,000 in attorneys' fees and expenses to resolve a putative class action lawsuit related to the By-laws Amendment of Solventum Corporation. The litigation, filed by Plaintiff Eric Gilbert against the Company, challenged certain advance notice and stockholder nomination provisions. To avoid further legal disputes, the Company opted for a settlement despite maintaining that all allegations were denied. This resolution aims to mitigate the costs and time associated with ongoing litigation in favor of a swift closure to the case.
- : SEC 8-K (5.02):
- : Solventum Corporation Announces Senior Leadership Transition
- : SEC 8-K (5.02):
- : SEC 8-K (5.02): On March 20, 2026, Mary Wilcox notified Solventum Corporation of her decision to retire and resign from her role as Chief Accounting Officer. The company will conduct a search to find and appoint her successor, marking a significant transition in the company's financial leadership. This departure may have strategic implications for Solventum’s financial reporting and governance practices as they seek to ensure continuity and stability in the accounting department.
- : Solventum acquires Acera Surgical to enhance portfolio
Leadership
- Phillip Hebb, Director-Engineering and Implementation
- John McKenna, Director, Engineering
- Neil Zieselman, Chief Accounting Officer
- Aisling Cuffe, Commercial Operations Support Specialist
- Adam Alderman, Project Engineering Specialist
- Leslie Mollner, Lead Ux Designer
- Andreas Syrek, Global Medical Director and Chief Dental Officer
- Cassie Dardon, Demonstration Systems Engineer
- Brian Whipple, Marketing Technology Customer Education
- Ben Stride, Senior Software Engineer
- Kevin Feeney, Sales Representative
Verified email and direct lines for Solventum’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Solventum files 3 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Solventum in the news
- Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026 - Yahoo Finance (Oct 15, 2026)
- Solventum Unveils Next-Generation Filtek Matrix Restorative System - Dentistry Today (Oct 20, 2026)
- Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy* - PR Newswire (Oct 19, 2026)
- Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026 - AOL.com (Oct 15, 2026)
- Turn up the heat - Nature (Aug 28, 2026)
- At 4:30 p.m. Eastern on Nov. 5, Solventum will discuss its quarterly results. - Stock Titan (Oct 15, 2026)
- Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026 - AOL.com (Oct 15, 2026)
- Solventum to Participate in the 2026 Wells Fargo Healthcare Conference - PR Newswire (Sep 02, 2026)
Companies similar to Solventum
- Mindray · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Zimmer · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Edwards Lifesciences · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Lumexa Imaging · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Masimo Corporation · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
About Solventum: questions and answers
What does Solventum do?
Solventum is a healthcare innovation company dedicated to enabling better, smarter, and safer care. Building on a long legacy of breakthrough solutions, we pioneer advancements at the intersection of health, materials, and data science—transforming patient outcomes and empowering healthcare professionals to perform at their best.
Where is Solventum headquartered?
Solventum is headquartered in Eagan, Minnesota, United States.
How many employees does Solventum have?
Solventum has about 20,000 employees.
What is the latest news on Solventum?
On Sep 03, 2026, Minnesota Wild Partners with Solventum to Promote Oral Health through Nordy’s Chipped Tooth Campaign
Is Solventum a public company?
Yes. Solventum is publicly traded under the ticker SOLV.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy